Salvia BioElectronics is a MedTech innovator pioneering a new direction in migraine treatment. Focused on neuromodulation, the company is developing MySalvia Therapy—an advanced, drug-free approach designed to target key nerves involved in chronic migraine. Built around ultra-thin implants and a wearable activation device, the technology is created to integrate seamlessly into everyday life. Founded in Eindhoven, Salvia operates globally across Europe, the United States, and Australia, driven by a team of experienced device makers and MedTech entrepreneurs.